Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease
1. About lecanemab (generic name, brand name: Leqembi®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...
Defense One4h
DHS releases guidance for AI in critical infrastructure
The Department of Homeland Security worked with its diverse AI Safety and Security Board to develop a holistic approach for ...
Airforce Technology on MSN14h
US DoD expands Replicator initiative with new drone selections
The US Department of Defense (DoD) has expanded its Replicator initiative by adding two new types of uncrewed aerial systems ...
National Geographic news21h
November 2024 Issue
In the medical field, being fast, efficient, and correct can be the difference between life and death. This game-changing tool is helping cancer researchers and doctors save lives.